Vascular Disease and Surgery

About

Heart transplantation surgery has become the standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-transplant care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of heart transplant recipients.

The number of heart transplants performed worldwide over the last decade has continued to increase annually.

Current challenges include older age of both recipients and donors; an increasing number of transplants performed with mechanical circulatory support; the growing use of combined organ transplants (now more than 4% of all heart transplants); and a high proportion of sensitised patients (those with pre-formed antibodies against human leukocyte antigens, which increased the risk of organ rejection).

Articles

Endovascular Abdominal Aortic Aneurysm Repair – Current Challenges in 2013

Citation:

Interventional Cardiology Review 2013;8(1):57–60

Basic Principles of Health Economics Applied - How to Assess if Transcatheter Aortic Valve Implantation is Worth the Investment

Citation:

Interventional Cardiology Review 2013;8(2):135-9

Concurrent Coronary Artery and Valvular Heart Disease - Hybrid Treatment Strategies in 2013

Citation:

Interventional Cardiology Review 2013;8(2):127-30

Current Concepts in the Clinical Utility of Platelet Reactivity Testing

Citation:

Interventional Cardiology Review 2013;8(2):100-6